Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics

Sawada, K., Hara, C. O., Kimura, T., & Morishige, K. I. (2012). Integrin Inhibitors as a Therapeutic Agent for Ovarian Cancer. Journal of Oncology, 2012(), 281-286-126. https://doi.org/10.1155/2012/915140
楊智雯（2016）。Development of subcellular-targeting nanodrug for cancer therapeutic strategy〔碩士論文，國立臺灣大學〕。華藝線上圖書館。https://doi.org/10.6342/NTU201602987
Koury, J., Zhong, L., & Hao, J. (2017). Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment. Stem Cells International, 2017(), 1-10-61. https://doi.org/10.1155/2017/2925869
Corrado, M., Scorrano, L., & Campello, S. (2012). Mitochondrial Dynamics in Cancer and Neurodegenerative and Neuroinflammatory Diseases. International Journal of Cell Biology, 2012(), 885-897. https://doi.org/10.1155/2012/729290
鄭秋敏（2008）。Targeting prodrug-activating vectors for selectivecancer therapy〔博士論文，高雄醫學大學〕。華藝線上圖書館。https://doi.org/10.6832/KMU.2008.00127